Evaluation of antiparasitic, anticancer, antimicrobial and hypoglycemic properties of organic extracts from Panamanian mangrove plants by Lopez, Dioxelis et al.
32
                               doi: 10.4103/1995-7645.223531                                               ©2018 by the Asian Pacific Journal of Tropical Medicine. All rights reserved. 
Evaluation of antiparasitic, anticancer, antimicrobial and hypoglycemic 
properties of organic extracts from Panamanian mangrove plants
Dioxelis Lopez1,2, Lilia Cherigo3, Alejandro de Sedas1,2, Carmenza Spadafora4, Sergio Martinez-Luis1 
1Centro de Biodiversidad y Descubrimiento de Drogas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), 
Edificio 219, Ciudad del Saber, Apartado 0843-01103, Panama, Republica de Panama
2Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, India
3Departamento de Química Orgánica, Facultad de Ciencias Exactas y Tecnología, Universidad de Panamá, P.O. Box 3366, Panama, Republica de 
Panama
4Centro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) 
Edificio 219, Ciudad del Saber, Apartado 0843-01103, Panama, Republica de Panama
ARTICLE INFO                           ABSTRACT
Article history:
Received 10 October 2017
Received in revised form 8 November 2017
Accepted 4 December 2017
Available online 2 January 2018
Keywords: 
Mangrove plants
Anticancer activity
Antibacterial activity
Antiparasitic activity
Alpha-glucosidase inhibition
 
      First author: Dioxelis López, Centro de Biodiversidad y Descubrimiento de Drogas, 
Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT 
AIP), Edificio 219, Ciudad del Saber, Apartado 0843-01103, Panamá, República de 
Panamá.
       E-mail: dlopez@indicasat.org.pa
  Corresponding author: Dr. Sergio Martínez-Luis, Centro de Biodiversidad y 
Descubrimiento de Drogas, Instituto de Investigaciones Científicas y Servicios de 
Alta Tecnología (INDICSASAT AIP), Edificio 219, Ciudad del Saber, Apartado 0843-
01103, Panamá, República de Panamá. 
     Tel: (507) 517-0700
     Fax: (507) 507-0020
     E-mail: smartinez@indicasat.org.pa
    Fund project: This work was partially supported by the National Secretariat for 
Science and Technology of Panama (SENACYT) [grant number FID14-063]. Dioxelis 
Lopez was supported by funds from the National Secretariat of Science, Technology 
and Innovation (SENACYT) doctoral [grant number 270-2011-154]. Lilia Cherigo and 
Sergio Martinez-Luis were supported by funds from the National Research System of 
SENACYT [SNI 147 2016 and SNI 145 2016, respectively].
1. Introduction
  Mangroves consist of a community of halophytic plants 
characteristic of intertidal areas of the tropical and subtropical 
coastlines. Mangroves around the world can be divided into two 
major geographic regions: those from the east area (spanning from 
Objective: To investigate 33 organic extracts of mangrove plants for: antiparasitic, anticancer, and antibacterial 
activities, as well as their ability to inhibit the activity of the 毩-glucosidase enzyme.  Methods: Leaves from all 
different plant mangrove species located in five mangrove zones of the Pacific coast of Panama were collected 
according to standard procedures. Qualitative phytochemical analysis of the organic extracts was performed by 
thin layer chromatography. The antiparasitic activity against Plasmodium falciparum, Trypanosoma cruzi and 
Leishmania donovani, toxicity against Artemia salina, anticancer activity in MCF-7 cell line, and antibacterial 
activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa of all 
organic extract were investigated according protocols stablished in our institution. Finally, the ability to inhibit 
the enzymatic activity of 毩-glucosidase was evaluated by monitoring the hydrolysis of p-nitrophenyl 毩-D-
glucopyranoside. Results: Thirty-three different samples belonging to nine different species of vascular plants 
with seeds of true mangroves were collected. Triterpenoids, phenolics, and tannins were the main groups of 
compounds found in the sampled mangroves. Saponins, quinones, and coumarins were found in less than 50% 
of the samples. Laguncularia racemosa showed moderate activity against Plasmodium falciparum. None of 
the extracts presented anticancer activity. Rhizophora mangle exhibited potent activity against Staphylococcus 
aureus and Bacillus subtilis [(90.41±7.33)% and (96.02±6.14)% of inhibition]; Avicennia germinans and 
Conocarpus erectus had activity against Escherichia coli [(71.17±6.15)% and (60.60±5.13)% of inhibition, 
respectively]. About 60% of the mangroves showed 毩-glucosidase inhibitory activity. In particular, extracts 
from Laguncularia racemosa, Pelliciera rhizophorae, Conocarpus erectus, Mora oleifera, and Tabebuia palustris 
species showed 毩-glucosidase inhibitory potential, with IC50 values of (29.45±0.29), (20.60±0.70), 
(730.06±3.74), (25.59±0.37), and (853.39±5.30) µg/mL,  respectively. Conclusions: Panamanian mangroves 
are mainly a promising potential source of hypoglycemic compounds, specifically 毩-glucosidase inhibitors. 
These results highlight the therapeutic virtues of extracts from American mangrove plants.
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west and central Pacific to the southern end of Africa) and those from 
the west region (covering the west coast of Africa and both coasts of 
the Americas)[1,2]. According to the World Atlas of Mangroves, the 
eastern area has a greater number of species (62) than the western 
area (12), with only two species in common between both zones[1]. 
For many years, mangroves have been utilized by various ethnic 
groups for the treatment of several diseases. Ethnopharmacological 
uses of different mangrove species have been very diverse and have 
included treatment for the following conditions and symptoms: eye 
problems, skin diseases, rheumatism, blisters, arthritis, hemorrhage, 
asthma, throat and stomach ache, infections, and diabetes[1,3]. 
Some species from Avicenniaceae, Meliaceae, Rhizophoraceae and 
Euphorbiaceae families have shown antimicrobial activity, while 
others belonging Meliaceae and Rhizophorae families possessed 
antimalarial properties. In turn, species from Acanthaceae and 
Myrsinaceae families demonstrated anticancer activity. Most existing 
studies that have previously evaluated the biological properties of 
mangrove plants have been carried out on eastern area species. In 
that part of the world, several scientific studies have supported the 
ethnomedical use of mangrove plants. On the other hand, there are 
very few reports, which have demonstrated the medicinal properties 
attributed to the mangrove plants from the western area species. 
This is a peculiar finding due to the extensive medicinal uses of 
this resource by various ethnic groups of several countries in the 
American continent[1,3-5].
  The lack of scientific evidence on the efficacy of the ethnomedical 
properties and toxicity attributed to mangrove plants could be a 
major health problem. Therefore, there is an urgent need to carry out 
scientific studies that will validate or refute the ethnomedical uses 
of mangrove plant species on the American continent. Additionally, 
these plants could be of utmost importance to global bioprospecting 
programs dedicated to searching new (chemical) alternatives to 
combat diseases of high-impact on humanity, especially if potential 
activities are found in the studies mentioned above, their ancestral/
past use increases their possible application.
  We consider that Panama is an ideal country to evaluate the 
bioactivity from west plant mangroves because 92% of the 
continental species (eleven of the twelve species for the whole 
continent) are in this country. Therefore, information generated from 
studies conducted in Panama could serve to provide an overview 
of the biological activities of mangrove plants in America. In 
this context, our research group decided to carry out a systematic 
evaluation of extracts from leaves of vascular plants belonging to 
Panamanian mangroves. We conducted antiparasitic [Plasmodium 
falciparum (P. falciparum), Trypanosoma cruzi (T. cruzi), and 
Leishmania donovani (L. donovani)], anticancer (MCF-7 cell 
lines), hypoglycemic (毩-glucosidase inhibition), and antibacterial 
bioassays with the purpose of generating scientific information 
that helps to promote the safe use of mangrove plants. As we have 
seen before, these studies are urgent and necessary, even more so if 
we take into account that mangrove forests are considered among 
the most vulnerable ecosystems on the planet, and they are more 
and more at risk of disappearing. In recent years, Panama has 
experienced an unprecedented and vast expansion in urbanization, 
as well as tourism infrastructure that have significantly affected 
mangrove areas in the country[6]. About 20% of the country's 
mangroves are in the Bay of Panama (central urban area), and the 
country has a lot of beautiful beaches (all with extensive mangrove 
areas). All of this suggests that the country’s most productive 
activities are located in the main area of mangrove coverage, and 
because of this situation, many hectares of Panamanian mangroves 
could disappear in a few years due to the great pressures of human 
activity on the environment[7,8].
2. Materials and methods
2.1. Plant material
  The leaves of nine different plant mangrove species were collected 
in five mangrove areas from the Pacific coast of Panama. Zones 1 
(Chame Bay) and two (Juan Diaz and Veracruz) were located in 
Panama Province, meanwhile zone 3 (Horconcito and Hermosa 
Beach) and 4 (la Barqueta beach and Pedregal Port) were visited 
in Chiriqui province. Finally, zone 5 (El salado beach) collected in 
Cocle province. This study focused on the Pacific region, due to 
96.5% of the country's mangrove forests being located in this area. 
  Samples were stored in black plastic bags and transported to the 
laboratory. The samples were rinsed with water and placed to dry 
at room temperature. Once dried, samples were pulverized and 
stored for further processing. In addition, plants were taxonomically 
identified, and voucher specimens were deposited at the Herbarium 
of the University of Panama (PMA) in Panama City, Panama. The 
accession numbers of the species are as follows: Avicennia bicolor 
(A. bicolor) 105807, Avicennia germinans (A. germinans) 107546, 
Conocarpus erectus (C. erectus) 105836, Laguncularia racemosa (L. 
racemosa) 107547, Mora oleifera (M. oleifera) 110761, Pelliciera 
rhizophorae (P. rhizophorae) 105838, Rhizophora mangle (R. mangle) 
105837, Rhizophora racemosa (R. racemosa) 107712, and Tabebuia 
palustris (T. palustris) 107539.
2.2. Preparation of extracts
  The extract from each plant was prepared by maceration with a 
mixture of chloroform: methanol (1:1). Extracts were concentrated 
using a rotary evaporator (Laborota 4010, Germany) and stored at
- 4 曟 until further usage.
2.3. Phytochemical analysis
  The crude extracts from mangrove leaves were subjected to 
qualitative tests to identify the families of secondary metabolites 
contained in each species through a visualized thin layer 
chromatography (TLC) profile employing several specific stain 
reagents. TLC plates with Silica gel 60 F254 (Sigma Aldrich, USA), 
as stationary phase, were used for this analysis. Extracts were drawn 
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with capillary tubes and applied as spots on TLC plates about 1 
cm from the base. Then, a spot of the successive samples were 
placed with 1 cm away from the previous sample to avoid cross-
contamination and interference as they move up during the elution 
process. TLC plates were placed into a chromatographic tank, 
which contained the appropriate mobile phase (Chloroform) at room 
temperature for the elution process. At the end of the elution process, 
plates were taken out from the chromatographic tank and dried. 
Spots in each extract were visualized under ultra-violet light at two 
wavelengths (UV 254 nm and UV 365 nm), and then plates were 
impregnated with chromogenic reagents.
  Presence of the different types of compounds that each organic 
extract contained, were qualitatively determined using the following 
specific reagents for plate visualization[9]: Borntrager reagent 
for the presence of quinones and coumarins.; p-anisaldehyde for 
the presence of steroids; vanillin–sulfuric acid for the presence 
of saponins and triterpenoids compounds; Liebbermann Buchard 
reagent for the presence of triterpenoids; Ferric chloride for the 
presence of phenolics compounds; Vanillin–chloridic acid for the 
presence of tannins.
2.4. In vitro antiparasitic assays
  Culture procedure: L. donovani parasites used in the assays were 
transformed from promastigote transformation into amastigote forms 
transferring 1 mL of promatigotes log phase culture into 5 mL of 
Medium 199 Modified (SIGMA-Cat M3769), and maintained at 
35 曟 until its use in bioassays. Meanwhile, P. falciparum parasite, 
chloroquine-resistant strain (Indochina W2), was kept in synchrony 
by thermal cycling incubation. Additionally, P. falciparum parasite 
were maintained in continuous log phase growth in RPMI-1640 
medium (SIGMA) at 37 曟 under an atmosphere of 5% CO2 and 
5% O2, with a balance of N2 (90%). T. cruzi parasite, (Tulahuen) 
C4 strain lactosidase (Lac Z) gene was maintained on VERO Cells 
(African Green Monkey cell line)[10]. T. cruzi parasite was grown in 
RPMI-1640 medium at 37 曟 under an atmosphere of 5% CO2/95% 
air mixture. Medium was supplemented with 10% heat inactivated 
FBS.
  Assays: Dry samples were diluted in 50 µL of DMSO 
(dimethylsulfoxide) to obtain a concentration of 4 mg/mL and 
screening in sterile 96-well microtitre culture plates (Costar Cat 
3595). Primary screenings was performed in duplicate wells, at a 
final concentration of 6.25 µg/mL.
  L. donovani and P. falciparum: Samples and parasite were incubated 
for 48 h. The amount of parasite in culture was determined using 
a DNA cross linking agent. PicoGreen® solution (1%) was added 
to wells, in a dark condition, after 48 and 72 h of incubation. Plate 
were shaken and read in a microplate reader set up to 485/20 nm 
for excitation step and to 528/20 nm for emission. Positive controls 
were Amphotericin B (IC50 = 70–120 ng/µL) for L. donovani and 
chloroquine (IC50 = 80–100 nmol/L) for P. falciparum[11].
  T. cruzi: Trypomastigotes (intracellular form) were exposed to test 
sample, in three different concentrations (50, 10 and 2 µg/mL) during 
120 h in 96-wells plate. The resulting colour from the cleavage of 
chlorophenol red-毬-D-galactoside (CPRG) by 毬-Gal expressed by 
the parasite was used to quantify the inhibition of parasite growth. 
Plates were read at 570 nm. Positive control was Nifurtimox (IC50 = 
0.15–13.4 µmol/L)[11,12].
2.5. Brine shrimp lethality assay
  In vitro lethality assay of Artemia salina (A. salina) was used for 
detecting toxicity from the organic extracts[13]. Brine shrimp eggs 
(2.5 g) were placed in artificial seawater solution (3.8% of instant 
ocean salt w/v in sterile water) and incubated at 28 曟. Solution was 
saturated with oxygen bubbling air with a fish tank pump. Eggs were 
hatched within 48 h providing a large number of larvae (nauplii). 
Test samples and positive control were prepared by dissolving 
0.6 mg in a solution containing 50 µL of DMSO and 550 µL of 
artificial seawater solution. Serial dilutions (1 000, 500, 250 and 
125 mg/L) were made in separated wells of 96-well microplate. 
Nauplii were placed in each well by pipetting them until deposited 
10–15 organisms. Each concentration was assessed by triplicate. 
Positive control was potassium dichromate, while negative control 
was the solvent for sample dissolution. Plate was incubated at 
28  曟. The percentage lethality was determined by comparing 
the mean surviving larvae of the test and control wells. Lethal 
concentrations values were obtained from the best-fit line plotted 
concentration versus percentage lethality. 
2.6. Cancer bioassay
  In a 96-well plate, 100 µL of RPMI buffer containing MCF-7 cells 
were added to each well and incubated for 24 h at 37 曟. Samples 
were diluted in DMSO to final concentration of 6.25 µg/mL and 
analyzed by duplicate. After the incubation period, 100 µL of sample 
was added to each well. Colour control was RPMI without cells and 
positive control was Adriamycin. The 96-well-plate was incubated 
for 48 h at 37 曟 under an atmosphere of 5% CO2/95% air mixture. 
After the incubation period, cells were fixed with 50% trichloroacetic 
acid for one hour, air dried and stained with sulforhodamine
B. Washing the 96-well-plate with 1% acetic acid removed excess 
of sulforhodamine B. Bound sulforhodamine B was dissolved with
10 mmol/L Tris. Plate was shaken and read in a microplate reader set 
up to 515 nm[14].
2.7. Antimicrobial bioassay
  The antimicrobial assay against Gram-positive Bacteria 
Staphylococcus aureus (S. aureus) (ATCC® 43300™) and Bacillus 
subtilis (B. subtilis) (ATCC® 6051™); Gram-negative Escherichia 
coli (E. coli) (ATCC® 10536™) and Pseudomonas aeruginosa (P. 
aeruginosa) (ATCC® 10145™) was performed according to Kumar et 
al., with some modifications[15]. Sterile 96-well microplates (Greiner 
bio-one 655101) were used for each assay. Samples solutions were 
tested by duplicate at 10 µg/mL. The bacterial solution was prepared 
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with turbidity comparable to the standard of 0.5 McFarland. Wells 
were filled with 20 µL of the bacterial solution, 5 µL of the sample 
solution, 95 µL of sterile water and 80 µL of Muller Hinton culture 
medium and incubated at 37 曟 for 24 h. Chloramphenicol instead 
of sample solution, DMSO instead of sample solution, sterile water 
instead of bacterial solution and non-bacterial solution instead of 
sample were used as positive, negative, color and sterility controls, 
respectively. After incubation period, bacteria growth inhibition 
was evaluated in a microplate reader at 750 nm. The activity of the 
sample was calculated as percentage of bacterial growth inhibition 
(% GI) according to the following equation:
  %GI = [Negative correction – Sample correction]/Negative 
correction ×100.
Where, Negative correction: Abs of negative control – Abs of 
sterility control; Sample correction: Abs of the samples – Abs of 
color control. 
2.8. 毩-glucosidase inhibitory assay
  The inhibition of 毩-glucosidase, from Saccharomyces 
cerevisiae (Sigma Chemical Co), function was measured 
spectrophotometrically[16], with modifications. The absorbance (A) 
of 4-nitrophenol released from the hydrolysis of p-nitrophenyl 
毩-D-glucopyranoside (PNP-G), 2 mmol/L, by enzyme solution (32 
mU/mL) in potassium phosphate buffer (100 mmol/L), was measured 
at 400 nm by Synergy HT Bio Tek microplate spectrophotometer. 
Samples, dissolved in DMSO or MeOH, were incubated for 7 min 
with 150 µL of enzyme solution at 37 曟 in 96-well microplates 
(Greiner bio-one 655101) by duplicate. After incubation period, 
150 µL of substrate (PNP-G) was added and incubated for another 
period of 20 min at 37 曟. Acarbose was use as positive control. 
The percentage of 毩-glucosidase inhibition function was calculated 
in comparison to a control (DMSO or MeOH instead of sample 
solution) according to the equation:
  %Inhibition= (∆Acontrol – ∆Asample)/∆Acontrol × 100%.
Where, ∆Acontrol: absorbance of the control – absorbance of the blank; 
∆Asample: absorbance of the sample – absorbance of the sample blank.
  Specific concentration of 毩-glucosidase enzyme solution (32 
mU/mL) were incubated with different concentrations of substrates 
(PNP-G) and inhibitors (active mangrove concentration equivalent 
to IC50) with the same conditions of 毩-glucosidase inhibitory 
assay. The results were plotted according to standard procedure for 
Lineweaver–Burk or double reciprocal. All the determinations were 
performed in triplicate.
2.9. Statistical analysis
  All collected data was reported as the mean±SD of three replicates. 
Analysis was carried out using Excel 2013. One-way analysis of 
variance (ANOVA) and Tukey posttest were used to evaluate the 
possible differences among the means. There were significant 
differences with P values ≤0.05.
3. Results 
3.1. Diversity of mangrove plants 
  In total, 33 mangrove’s samples from nine different species 
were collected from different places along the Pacific coast of the 
Republic of Panama, from 2011 to 2013 (Table 1). 
Table 1
Species of mangrove plants collected and identified from the Pacific Coast of 
Panama.
Code Plant species Family Coordinates
ML-M-001 Conocarpus erectus Combretaceae 8°39'29.2"N 79°48'10.8"W
ML-M-002 Laguncularia racemosa Combretaceae 8°39'29.2"N 79°48'10.8"W
ML-M-003 Pelliciera rhizophorae Pellicieraceae 8°39'29.2"N 79°48'10.8"W
ML-M-004 Rhizophora mangle Rhizophoraceae 8°39'29.2"N 79°48'10.8"W
ML-M-005 Laguncularia racemosa Combretaceae 9°01'04.1"N 79°26'14.0"W 
ML-M-006 Avicennia germinans Avicenniaceae 9°01'04.1"N 79°26'14.0"W 
ML-M-007 Conocarpus erectus Combretaceae 8°55'34.5"N 79°33'56.0"W
ML-M-008 Rhizophora mangle Rhizophoraceae 8°55'34.5"N 79°33'56.0"W
ML-M-009 Laguncularia racemosa Combretaceae 8°19'17.8"N 82°09'31.7"W
ML-M-010 Avicennia germinans Avicenniaceae 8°19'17.8"N 82°09'31.7"W
ML-M-011 Conocarpus erectus Combretaceae 8°13'15.8"N 82°09'42.9"W
ML-M-012 Rhizophora mangle Rhizophoraceae 8°13'15.8"N 82°09'42.9"W
ML-M-013 Avicennia germinans Avicenniaceae 8°13'15.8"N 82°09'42.9"W
ML-M-014 Pelliciera rhizophorae Pellicieraceae 8°17'37.0"N 82°30'32.9"W
ML-M-015 Rhizophora mangle Rhizophoraceae 8°17'37.0"N 82°30'32.9"W
ML-M-016 Conocarpus erectus Combretaceae 8°17'37.0"N 82°30'32.9"W
ML-M-017 Avicennia bicolor Avicenniaceae 8°17'37.0"N 82°30'32.9"W
ML-M-018 Avicennia bicolor Avicenniaceae 8°12'00.4"N 80°29'00.7"W
ML-M-019 Conocarpus erectus Combretaceae 8°12'00.4"N 80°29'00.7"W
ML-M-020 Rhizophora racemosa Rhizophoraceae 8°12'00.4"N 80°29'00.7"W
ML-M-021 Rhizophora mangle Rhizophoraceae 8°12'00.4"N 80°29'00.7"W
ML-M-022 Laguncularia racemosa Combretaceae 8°12'00.4"N 80°29'00.7"W
ML-M-023 Avicennia germinans Avicenniaceae 8°12'00.4"N 80°29'00.7"W
ML-M-024 Mora oleifera Caesalponiaceae 8°12'00.4"N 80°29'00.7"W
ML-M-025 Tabebuia palustris Bignoniaceae 8°12'00.4"N 80°29'00.7"W
ML-M-026 Pelliciera rhizophorae Pellicieraceae 8°12'00.4"N 80°29'00.7"W
ML-M-027 Rhizophora mangle Rhizophoraceae 8°12'00.4"N 80°29'00.7"W
ML-M-028 Mora oleifera Caesalponiaceae 8°21'34.4"N 82°25'59.8"W
ML-M-029 Pelliciera rhizophorae Pellicieraceae 8°21'34.4"N 82°25'59.8"W
ML-M-030 Avicennia germinans Avicenniaceae 8°21'34.4"N 82°25'59.8"W
ML-M-031 Pelliciera rhizophorae Pellicieraceae 8°21'34.4"N 82°25'59.8"W
ML-M-032 Laguncularia racemosa Combretaceae 8°21'34.4"N 82°25'59.8"W
ML-M-033 Tabebuia palustris Bignoniaceae 8°21'34.4"N 82°25'59.8"W
3.2. Phytochemical analysis
  Preliminary phytochemical TLC screening of the cloroformo: 
metanol (1:1) extracts of different species from the collected 
mangroves revealed the presence of various groups of compounds 
(triterpenoids, phenolics, tannins, saponins, quinones, and 
coumarins). This data was obtained according to the colours 
observed on the spot extracts when each specific reagent was added. 
Results are summarized in Table 2. 
3.3. Antiparasitic activity of the tested plants
  In the antiparasitic assays, samples were tested at 6.25 µg/mL. Only 
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one sample belonging to L. racemosa species showed antiparasitic 
activity, in particular against P. falciparum [(60.1±3.1)% inhibition], 
the rest of the samples were inactive or showed weak activity which 
was equal to or less than 30% of inhibition.
3.4. Anticancer activity of the tested plants
  None of the extracts (tested at 6.25 µg/mL) showed considerable 
anticancer activity, so all extracts were discarded for further 
anticancer evaluations.
3.5. Toxicity of the tested plants against A. salina 
  Only three sample (P. rhizophorae, C. erectus, and A. bicolor) showed 
concentration that killed the 50% of nauplii (IC50) below of 1 000 
mg/L [IC50 = (883.0±14.3), (963.0±13.1) and (368.0±9.0) mg/L, 
respectively). In fact, the toxicity that resulted for A. bicolor sample 
was the only one that could draw our attention. 
3.6. Antibacterial activity of the tested plants
  The antibacterial activities of the 33 extracts were assayed in vitro 
by the agar microdilution method against four bacteria (S. aureus, 
B. subtilis, E. coli and P. aeruginosa) at 6.25 µg/mL. Among the 
mangroves plants, only R. mangle exhibited strong activity against 
S. aureus and B. subtilis (four samples with inhibition between 90%–
96%), while an A. germinans extract had activity against E. coli 
[(71.1±1.9)% of inhibition] and a C. erectus extract showed moderate 
activity against E. coli [(60.1±1.0)% of inhibition]. Finally, none of 
the extracts showed activity against P. aeruginosa. 
3.7. 毩-glucosidase inhibition evaluation of the tested plants
  Extracts from five species from a total of nine-collected showed 
activity showed inhibition of 毩-glucosidase enzyme, with effects 
ranging from moderate to relatively high. In particular, extracts 
from L. racemosa, P. rhizophorae, C. erectus, M. oleifera, and T. 
palustris species showed 毩-glucosidase enzyme inhibitory potential, 
with IC50 values of (29.45±0.29), (20.60±0.70), (730.06±3.74), 
(25.59±0.37), and (853.39±5.30) µg/mL, respectively. Among these 
five-plant mangrove extracts, L. racemosa, P. rhizophorae and M. 
oleifera possessed better hypoglycaemic activity than the positive 
control [Acarbose, IC50 value of (140.55±4.30) µg/mL]. 
  Lineweaver–Burk kinetic analyses were performed to characterize 
the enzymatic inhibition mode of active plant extracts against 
毩 -glucosidase (Figure 1). Michaelis–Menten constant (Km) and 
Maximum reaction velocity (Vmax) values of the mangrove plant 
extracts against 毩-glucosidase were calculated (Table 3). 
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Figure 1. Lineweaver–Burk plot of 毩-glucosidase inhibition in the presence 
of active plant mangrove extracts.
Reaction velocity (V) in unit of mmol/(L·min). PNP-G (p-nitrophenyl 
毩-D-glucopyranoside) in unit of mmol/L. 
Table 2
Phytochemical analysis of organic extracts of mangrove samples from the Pacific Coast of Panama.
Compound Test applied Pelliciera 
rhizophorae
Avicennia
 germinans
Rhizophora
 mangle
Avicennia
 bicolor
Conocarpus
 erectus
Rhizophora
 racemosa
Laguncularia
racemosa
Mora
oleifera
Tabebuia
palustris
Triterpenoids Ammonium Molibdate ++ +++ +++ +++ ++ ++ + ++ +
Triterpenoids Lieberman–Burchard +++ +++ +++ ++ ++ +++ +++ ++ +
Phenols Ferric chloride +++ +++ +++ - - ++ ++ + -
Tannins Vanillin–chloridic acid + + ++ + + ++ + - -
Saponins Vanillin–sulfuric acid - - + - - + + + -
Steroids p-Anisaldehyde - - - - + - - + +
Quinones and coumarins Borntrager - - +++ - - - - - -
- = negative; + = slightly positive; ++ = moderate positive; +++ = highly positive.
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Table 3
Kinetic parameters of 毩-glucosidase inhibition by mangrove plants extracts
Samples Km (mmol/L) Vmax [mmol/(L•min)]
毩-glucosidase 0.365±0.001 0.004 1±0.000 1
L. racemosa 0.927±0.003 0.004 1±0.000 1
P. rhizophorae 0.943±0.002 0.004 1±0.000 2
C. erectus 0.833±0.001 0.004 1±0.000 1
M. oleifera 0.365±0.001 0.001 5±0.000 1
T. palustris 0.313±0.002 0.002 8±0.000 2
Km = Michaelis–Menten constant; Vmax = Maximum reaction velocity.
4. Discussion
4.1. Diversity of mangrove plants 
  In Panama, mangrove forests are relatively simple containing very 
few species, although this country is one of the most biodiverse in 
the western mangrove zone. The Word Atlas of Mangroves reports 
that Panama has 10 species of vascular plants with seeds belonging 
to true mangrove plants category[1]. In our collection trips, we 
collected 33 different samples belonging to nine different species of 
vascular plants with seeds of true mangroves. Rhizophora harrisonii 
was not located in any of the points we visited; this was the only 
species reported for the country that we were unable to find. On the 
other hand, R. mangle, L. racemosa, P. rhizophorae and C. erectus 
were the most abundant species.
4.2. Phytochemical analysis
  The dominant groups of compounds detected in the preliminary 
phytochemical analysis were triterpenoids and phenolics, and they 
have also been identified in several mangrove species belonging 
to the eastern mangrove zone. This helps us to conclude that 
the geographic location does not seem to affect the secondary 
metabolism of mangrove plants[4,17-19]. Based on our results, 
tannins represent the second most abundant group of compounds 
among all the samples of mangroves collected in Panama. Tannins 
gave positive reactions in 77% of the samples. Several authors have 
reported the presence of tannins in the mangroves of the eastern 
mangrove zone[20,21]. Other types of compounds that were present in 
the mangrove samples of the Pacific Coast of Panama were saponins, 
steroids, quinones and coumarins. The latter group of compounds 
was present in less than 50% of the samples. The presence of these 
compounds has also been described for mangroves in the eastern 
mangrove zone[22-24]. Quinones and coumarins were only present 
in the samples of R. mangle, which can be considered as a group of 
selective compounds for this type of mangroves in the region.
4.3. Anticancer and antiparasitic activities of the tested plants 
  The increasing of resistance from bacteria, cancer cells and 
parasites is common nowadays. For this reason, the human being is 
in a constant search for new treatments to combat all these malignant 
agents. Plants have been a traditional source of compounds with 
therapeutic potential, so it would not be a surprise that in scarcely 
studied plants we could found potential drugs. In the case of the 
plants evaluated in the present study, they lack antiparasitic and 
anticancer activities, which does not surprise us due to there are 
not many reports about similar sources with these activities. Only 
one sample belonging to L. racemosa species showed antiparasitic 
activity against P. falciparum[(60.1±3.1)% inhibition], the rest of the 
samples were inactive or showed weak activity which was equal to 
or less than 30% of inhibition.
4.4. Toxicity of the tested plants against A. salina 
  A. salina lethality test is perhaps the simplest cytotoxicity bioassay, 
and it is widely used in the evaluation of toxicity of natural plant 
extracts. Of all the samples tested, only one sample belonging to A. 
bicolor species shows an IC50 denoting potential toxicity in its plant 
extract, the remaining samples are lacking in vitro toxicity. This 
data suggests that Panamanian mangrove plants could have a high 
innocuity.
4.5. Antibacterial activity of the tested plants
  With the results of the antibacterial evaluation obtained in the 
present study, we can highlight two important observations. First, 
mangroves samples collected possess activity against Gram-
positive and Gram-negative bacteria. In the case of the A. germinans 
mangrove, there are studies of samples gathered in India and Iran 
which have activity against Gram-positive bacteria (S. aureus and 
Bacillus sp.) and Gram-negative bacteria (E. coli), respectively[25,26]. 
On the other hand, C. erectus mangrove has various reports in both 
the American and Asian regions. In America, studies with samples 
collected in Florida, demonstrate the potential of the C. erectus to 
inhibit quorum sensing in P. aeruginosa[27]. While samples gathered 
in Iraq showed activities against Streptococcus pneumonia and E. 
coli[28]. Second, R. mangle mangrove, collected in Panama, possesses 
specific activity against Gram-positive. The antibacterial activity of 
some R. mangle has also been reported in Brazil, where it was active 
against Gram-positive bacteria (S. aureus and Micrococcus luteus)[29].
4.6. 毩-glucosidase inhibition evaluation of the tested plants
  Postprandial high blood glucose leads to the appearance of vascular 
complications associated with diabetes[30]. 毩-Glucosidase, a key 
enzyme related to diabetes mellitus, is an intestinal enzyme that 
breaks down the carbohydrates to monosaccharide. Therefore, its 
inhibition delays the absorption of ingested carbohydrates and thus 
decreasing postprandial blood glucose and insulin peaks. In the 
traditional medicine of different countries, there are medicinal plants 
preparations with reputed hypoglycaemic effect[31-33]. In the case 
of mangrove plants in the west zone, there are a lot of reports on its 
ethnomedical use for the treatment of diabetes mellitus[23,34]. In fact, 
Rhizophora mucronata and Sonneratia apetala have been shown to 
exert part of their effect by inhibiting the 毩-glucoside enzyme, with 
IC50 values of 9.45 and 286 µg/mL, respectively[35,36].   
  In our case, samples of five different mangrove species, from 
a total of nine, showed activity. This represents about of 55% of 
active species, which compared with other ecosystems is a relatively 
high percentage of bioactive samples. On the other hand, this 
also suggests that this ecosystem could be a prolific producer of 
毩 -glucosidase inhibitory compounds. Reviewing in the literature, 
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we found that the IC50 value of three evaluated species (L. racemosa, 
P. rhizophorae and M. oleifera) is very similar to those of two 
species of plants from the other mangrove zone, which have a wide 
traditional use as antidiabetics.
  On the other hand, these results also support the use of species 
L. racemosa, P. rhizophorae and M. oleifera in traditional medicine 
as hypoglycaemic agents. This latter statement is supported by 
comparing the activity found in these mangrove plants with 
Rhizophora mucronata and Sonneratia apetala activities, and with 
the activity of other widely used plants in traditional medicine such 
as Erythroxylum laurifolium, Elaeodendron orientale, Antidesma 
madagascariensis, Stillingia lineata (IC50 values of these three plants 
were between 87.41 and 96.87 µg/mL)[37], Euclea undulata (IC50 
value of 49.95 µg/mL)[38], and Symplocos cochinchinensis (IC50 value 
of 82.07 µg/mL)[39]. In the case of C. erectus and T. palustris, their 
IC50 values were not good enough to support their efficient use in 
humans as hypoglycemic agents, although their moderate activity 
could be due to the very low amount of active compounds they 
contain. However, both plants could still be potential sources of 
hypoglycemic molecules.
  Finally, by correlating the results of the hypoglycemic activity 
test with those of the phytochemical study, we observed that all 
the samples that possess 毩-glucosidase inhibitory properties were 
positive for the presence of triterpenoids and phenols. These results 
are in agreement with previous reports on the 毩-glucosidase 
inhibitory properties of both types of chemical compounds and their 
presence in several plants with antidiabetic ethnomedical uses[34,40]. 
Therefore, it is very likely that these types of compounds are 
responsible for the enzymatic inhibition in the extracts evaluated.
To determine the enzymatic inhibition type we proceeded to calculate 
the Km and Vmax values using different concentrations of inhibitor 
and substrate, to generate Lineweaver–Burk graphic of each specie. 
As compared with uninhibited reaction, L. racemosa, P. rhizophorae 
and C. erectus presented an increase in Km; meanwhile, the Vmax 
remained the same, this is the characteristic feature of a competitive 
inhibitor. On the other hand, M. oleifera produced a decrease in Vmax 
value, while the Km was not affected; this feature describes a non-
competitive inhibition. Finally, T. palustris Lineweaver–Burk plot 
showed two parallels lines that mean the inhibitor reduced both Vmax 
and Km values; this is a typical for an uncompetitive inhibitor. Also, 
these samples showed the presence of triterpenoids and phenols. 
There are several publications that describe competitive[41,42] 
and non-competitive[41,43-45] inhibition produced by this kind of 
chemical compounds.
  In conclusion, at least three of the nine species (L. racemosa, P. 
rhizophorae, and M. oleifera) of Panamanian mangrove plants showed 
an excellent in vitro inhibition of the enzyme 毩-glucosidase, 
their activity was greater than that of acarbose, a hypoglycemic 
drug used as positive control. Extracts from L. racemosa and P. 
rhizophorae exhibited a competitive type of inhibition, and M. oleifera 
extracts displayed a non-competitive mode of inhibition against 
毩-glucosidase. According to the phytochemical analysis of plant 
mangroves extracts and the available literature, triterpenoids and 
phenols seem to be the compounds responsible for the enzymatic 
inhibition in the extracts evaluated. Except for certain species, 
which showed remarkable activity, mangroves plant extracts 
from Panama, demonstrated a poor antiparasitic, cytotoxic and 
antibacterial potential. In general terms, in vitro inhibitory properties 
against 毩-glucosidase enzyme were far superior to the antiparasitic, 
antibacterial and cytotoxic properties of these mangrove plants. 
Based on the results reported herein, it can be concluded that 
Panamanian mangroves are a promising potential source of 
hypoglycaemic compounds, specifically 毩-glucosidase inhibitors. 
Due to the evident hypoglycemic potential, Panamanian mangroves 
studies will be underway to investigate the bioactive metabolites and 
the detailed mechanisms of action of these bioactive metabolites in 
extracts.
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